Kihara James 4
4 · ACADIA PHARMACEUTICALS INC · Filed May 19, 2025
Insider Transaction Report
Form 4
Kihara James
PRINCIPAL ACCOUNTING OFFICER
Transactions
- Sale
Common Stock
2025-05-16$20.00/sh−2,000$40,000→ 20,395 total - Sale
Common Stock
2025-05-16$25.00/sh−2,000$50,000→ 22,395 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024.
- [F2]Includes 869 shares of the Issuer's common stock acquired by the Reporting Person on May 15, 2025 pursuant to an employee stock purchase plan.